Novadip Press Release
2025-06-20

Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia

Novadip is developing NVD003, an…
read more
Astrivax Press Release
2025-06-12

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

US-based Dieter Weinand is the…
read more
Astrivax Press Release
2025-06-10

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using LaunchiT technology

Third asset to advance into…
read more
Press Release Tubulis
2025-05-21

Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

The program, licensed exclusively to…
read more
Novadip Press Release
2025-04-29

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

No refractures were reported during…
read more
Novadip Press Release
2025-04-24

Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogeneic product, in spine fusion

Novadip reports key nonclinical and…
read more
Minoryx Press Release
2025-03-04

Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy

Minoryx announces dosing of the…
read more
ONA Press Release
2025-02-19

ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors

Ona Therapeutics Strengthens Leadership Team…
read more
Novadip Press Release
2024-10-17

Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a new game changer in the bone field

At six months post-grafting surgery…
read more
Confo Therapeutics Press Release
2024-07-29

Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

• Proceeds to support Phase…
read more